Towards understanding acute destabilization of vulnerable atherosclerotic plaques

Cardiovascular Pathology

Volumn 12, Issue 5, 2003, Pages 237-248

  Dickson, Brendan C ^b   Gotlieb, Avrum I ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

Atherosclerosis; Fibroinflammatory; Hemodynamics; Inflammation; Matrix; Plaque rupture; Unstable plaque; Vulnerable plaque

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN;

APOPTOSIS; ARTERY CALCIFICATION; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; CELL DEATH; CORONARY ARTERY SPASM; CORONARY ARTERY THROMBOSIS; DIAGNOSTIC IMAGING; DISEASE MARKER; DISEASE PREDISPOSITION; DISEASE SEVERITY; FIBROMUSCULAR DYSPLASIA; GENE EXPRESSION; HUMAN; LIPID STORAGE; MORPHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE FIBER;

EID: 0141514575     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(03)00072-3     Document Type: Article

References (135)

1. Shah P.K. Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. Prog Cardiovasc Dis. 44:2002;357-368.
2. Davies M.J. Going from immutable to mutable atherosclerotic plaques. Am J Cardiol. 88:2001;2F-9F.
3. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W., Rosenfeld M.E., Schwartz C.J., Wagner W.D., Wissler R.W. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 92:1995;1355-1374.
4. Gotlieb A.I., Silver M.D. Atherosclerosis: morphology and pathogenesis cardiovascular pathology. Silver M.D., Gotlieb A.I., Schoen F.J. Cardiovasc Pathol. 2001;68-106 Churchill Livingstone, New York.
5. Stary H.C. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol. 20:2000;1177-1178.
6. Schwartz S.M., Hatsukami T.S., Yuan C. Molecular markers, fibrous cap rupture, and the vulnerable plaque: new experimental opportunities. Circ Res. 89:2001;471-473.
7. Virmani R., Kolodgie F.D., Burke A.P., Farb A., Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 20:2000;1262-1275.
8. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 316:1987;1371-1375.
9. Libby P. Changing concepts of atherogenesis. J Intern Med. 247:2000;349-358.
10. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 21:2001;1876-1890.
11. Kaartinen M., van der Wal A.C., van der Loos C.M., Piek J.J., Koch K.T., Becker A.E., Kovanen P.T. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol. 32:1998;606-612.
12. Oliver M.F., Davies M.J. The atheromatous lipid core. Eur Heart J. 19:1998;16-18.
13. Ravn H.B., Falk E. Histopathology of plaque rupture. Cardiol Clin. 17:1999;263-270.
14. Moulton K.S. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep. 3:2001;225-233.
15. Werner N., Priller J., Laufs U., Endres M., Bohm M., Ulrich D., Nickenig G. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition. Arterioscler Thromb Vasc Biol. 2002;1567-1572.
16. Freedman S.B., Isner J.M. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med. 136:2002;54-71.
17. Simonini A., Moscucci M., Muller D.W., Bates E.R., Pagani F.D., Burdick M.D., Strieter R.M. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation. 101:2000;1519-1526.
18. Sullivan G.W., Sarembock I.J., Linden J. The role of inflammation in vascular diseases. J Leukoc Biol. 67:2000;591-602.
19. Davies M.J. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation. 94:1996;2013-2020.
20. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation. 92:1995;657-671.
21. Pasterkamp G., Falk S. Atherosclerotic plaque rupture: an overview. J Clin Basic Cardiol. 3:2000;81-86.
22. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the unstable plaque. Prog Cardiovasc Dis. 44:2002;349-356.
23. Kolodgie F.D., Burke A.P., Farb A., Gold H.K., Yuan J., Narula J., Finn A.V., Virmani R. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 16:2001;285-292.
24. Rabbani R., Topol E.J. Strategies to achieve coronary arterial plaque stabilization. Cardiovasc Res. 41:1999;402-417.
25. Cheng G.C., Loree H.M., Kamm R.D., Fishbein M.C., Lee R.T. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation. 87:1993;1179-1187.
26. Lendon C.L., Davies M.J., Born G.V., Richardson P.D. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis. 87:1991;87-90.
27. Shah P.K. Plaque disruption and thrombosis. Potential role of inflammation and infection. Cardiol Clin. 17:1999;271-281.
28. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:1994;36-44.
29. Burke A.P., Kolodgie F.D., Farb A., Weber D., Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 105:2002;297-303.
30. Farb A., Burke A.P., Tang A.L., Liang T.Y., Mannan P., Smialek J., Virmani R. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 93:1996;1354-1363.
31. Dimmeler S., Haendeler J., Galle J., Zeiher A.M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation. 95:1997;1760-1763.
32. Wong M.K.K., Gotlieb A.I. The reorganization of microfilaments, centrosomes, and microtubules during in vitro small wound reendothelialization. J Cell Biol. 107:1988;1777-1783.
33. Ettenson D.S., Gotlieb A.I. Basic fibroblast growth factor is a signal for the initiation of centrosome redistribution to the front of migrating endothelial cells at the edge of an in vitro wound. Arterioscler Thromb Vasc Biol. 15:1995;515-521.
34. Lee J., Gotlieb A.I. Microtubule-actin interactions may regulate endothelial integrity and repair. Cardiovasc Pathol. 11:2002;135-140.
35. Lee T-YJ, Gotlieb A.I. Rho and bFGF involvement in centrosome redistribution and actin microfilament remodeling during early endothelial wound repair. J Vasc Surg. 35:2002;1242-1252.
36. Murugesan G., Chisolm G.M., Fox P.L. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol. 120:1993;1011-1019.
37. Vyalov S., Langille B.L., Gotlieb A.I. Decreased blood flow rate disrupts endothelial repair in vivo. Am J Pathol. 149:1996;2107-2118.
38. Braganza D.M., Bennett M.R. New insights into atherosclerotic plaque rupture. Postgrad Med J. 77:2001;94-98.
39. Lutgens E., de Muinck E.D., Kitslaar P.J., Tordoir J.H., Wellens H.J., Dacmen M.J. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res. 41:1999;473-479.
40. Bennett M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res. 41:1999;361-368.
41. Shah P.K., Falk E., Badimon J.J., Fernandez-Ortiz A., Mailhac A., Villareal-Levy G., Fallon J.T., Regnstrom J., Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 92:1995;1565-1569.
42. Burke A.P., Kolodgie F.D., Farb A., Weber D.K., Malcom G.T., Smialek J., Virmani R. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation. 103:2001;934-940.
43. van der Wal A.C., Becker A.E. Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovasc Res. 41:1999;334-344.
44. Becker A.E., de Boer O.J., van der Wal A.C. The role of inflammation and infection in coronary artery disease. Annu Rev Med. 52:2001;289-297.
45. Cybulsky M.I., Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 251:1991;788-791.
46. Zebrack J.S., Anderson A.J. The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease. Curr Cardiol Rep. 4:2002;278-288.
47. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868.
48. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 90:2002;251-262.
49. Kaartinen M., Penttila A., Kovanen P.T. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation. 94:1996;2787-2792.
50. Kovanen P.T. The mast cell - a potential link between inflammation and cellular cholesterol deposition in atherogenesis. Eur Heart J. 14(Suppl K):1993;105-117.
51. Laine P., Kaartinen M., Penttila A., Panula P., Paavonen T., Kovanen P.T. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 99:1999;361-369.
52. Xu Q.B., Oberhuber G., Gruschwitz M., Wick G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol. 56:1990;344-359.
53. Emeson E.E., Shen M.L., Bell C.G., Qureshi A. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol. 149:1996;675-685.
54. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transder of CD4+ T cells aggrevates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation. 102:2000;2919-2922.
55. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 394:1998;200-203.
56. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 92:1995;3893-3897.
57. Johnson W.D., Moses J., Kipshidze N. Absence of Chlamydia pneumoniae in surgical specimens of coronary and carotid arteries by polymerase chain reaction. Cardiovasc Radiat Med. 2:2001;221-224.
58. de Boer O.J., van der Wal A.C., Houtkamp M.A., Ossewaarde J.M., Teeling P., Becker A.E. Unstable atherosclerotic plaques contain T-cells that respond to Chlamydia pneumoniae. Cardiovasc Res. 48:2000;402-408.
59. de Boer O.J., van der Wal A.C., Verhagen C.E., Becker A.E. Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques. J Pathol. 188:1999;174-179.
60. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 17:1996;138-146.
61. Frostegard J., Ulfgren A.K., Nyberg P., Hedin U., Swedenborg J., Andersson U., Hansson G.K. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 145:1999;33-43. Jul.
62. de Boer O.J., van der Wal A.C., Becker A.E. Atherosclerosis, inflammation, and infection. J Pathol. 190:2000;237-243.
63. Pinderski L.J., Fischbein M.P., Subbanagounder G., Fishbein M.C., Kubo N., Cheroutre H., Curtiss L.K., Berliner J.A., Boisvert W.A. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res. 90:2002;1064-1071.
64. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest. 99:1997;2752-2761.
65. Whitman S.C., Ravisankar P., Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma. Circ Res. 90:2002;E34-E38.
66. Lee T.S., Yen H.C., Pan C.C., Chau L.Y. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 19:1999;734-742.
67. Houtkamp M.A., van Der Wal A.C., de Boer O.J., van Der Loos C.M., de Boer P.A., Moorman A.F., Becker A.E. Interleukin-15 expression in atherosclerotic plaques: an alternative pathway for T-cell activation in atherosclerosis? Arterioscler Thomb Vasc Biol. 21:2001;1208-1213.
68. Ivan E., Khatri J.J., Johnson C., Magid R., Godin D., Nandi S., Lessner S., Galis Z.S. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation. 105:2002;2686-2691.
69. Varnava A.M., Mills P.G., Davies M.J. Relationship between coronary artery remodeling and plaque vulnerability. Circulation. 105:2002;939-943.
70. Hunt J.L., Fairman R., Mitchell M.E., Carpenter J.P., Golden M., Khalapyan T., Wolfe M., Neschis D., Milner R., Scoll B., Cusack A., Mohler E.R. Bone formation in carotid plaques: a clinicopathological study. Stroke. 33:2002;1214-1219.
71. Jeziorska M., McCollum C., Wooley D.E. Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries. Virchows Arch. 433:1998;559-565.
72. MacIsaac A.I., Thomas J.D., Topol E.J. Toward the quiescent coronary plaque. J Am Coll Cardiol. 22:1993;1228-1241.
73. Felton C.V., Crook D., Davies M.J., Oliver M.F. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol. 17:1997;1337-1345.
74. Small D.M. George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. Arteriosclerosis. 8:1998;103-129.
75. Loree H.M., Tobias B.J., Gibson L.J., Kamm R.D., Small D.M., Lee R.T. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb. 14:1994;230-234.
76. de Boer O.J., van der Wal A.C., Teeling P., Becker A.E. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res. 41:1999;443-449.
77. Fryer J.A., Myers P.C., Appleberg M. Carotid intraplaque hemorrhage: the significance of neovascularity. J Vasc Surg. 6:1987;341-349.
78. Friedman M. The pathogenesis of coronary plaques, thromboses, and hemorrhages: an evaluative review. Circulation. 52:1975;III34-III40.
79. Bank A.J., Versluis A., Dodge S.M., Douglas W.H. Atherosclerotic plaque rupture: a fatigue process? Med Hypotheses. 55:2000;480-484.
80. Bogaty P., Hackett D., Davies G., Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation. 90:1994;5-11.
81. Gertz S.D., Roberts W.C. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol. 66:1990;1368-1372.
82. Ardissino D., Merlini P.A., Arlens R., Coppola R., Bramucci E., Lucreziotti S., Repetto A., Fetiveau R., Mannucci P.M. Tissue factor in human coronary atherosclerotic plaques. Clin Chim Acta. 291:2000;235-240.
83. Zaman A.G., Helft G., Worthley S.G., Badimon J.J. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis. 149:2000;251-266.
84. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
85. Buja L.M., Willerson J.T. Role of inflammation in coronary plaque disruption. Circulation. 89:1994;503-505.
86. Aiello R.J., Bourassa P.A., Lindsey S., Weng W., Natoli E., Rollins B.J., Milos P.M. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 19:1999;1518-1525.
87. Davies M.J., Bland J.M., Hangartner J.R., Angelini A., Thomas A.C. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J. 10:1989;203-208.
88. Bennett M.R. Breaking the plaque: evidence for plaque rupture in animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 22:2002;713-714.
89. Geary R.L., Nikkari S.T., Wagner W.D., Williams J.K., Adams M.R., Dean R.H. Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg. 27:1998;96-106.
90. Rosenfeld M.E., Polinsky P., Virmani R., Kauser K., Rubanyi G., Schwartz S.M. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol. 20:2000;2587-2592.
91. Seo H.S., Lombardi D.M., Polinsky P., Powell-Braxton L., Bunting S., Schwartz S.M., Rosenfeld M.E. Peripheral vascular stenosis in apolipoprotein E-deficient mice. Potential roles of lipid deposition, medial atrophy, and adventitial inflammation. Arterioscler Thromb Vasc Biol. 17:1997;3593-3601.
92. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 14:1994;133-140.
93. Williams H., Johnson J.L., Carson K.G., Jackson C.L. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 22:2002;788-792.
94. Johnson J.L., Jackson C.L. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis. 154:2001;399-406.
95. Calara F., Silvestre M., Casanada F., Yuan N., Napoli C., Palinski W. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol. 195:2001;257-263.
96. Caligiuri G., Levy B., Pernow J., Thoren P., Hansson G.K. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A. 96:1999;6920-6924.
97. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 2:1998;275-281.
98. Boring L., Gosling J., Clearly M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
99. Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese R.V., Broxmeyer H.E., Charo I.F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest. 100:1997;2552-2561.
100. Reidy M.A., Fingerle J., Lindner V. Factors controlling the development of arterial lesions after injury. Circulation. 86:1992;1143-1146.
101. Roque M., Kim W.J., Gazdoin M., Malik A., Reis E.D., Fallon J.T., Badimon J.J., Charo I.F., Taubman M.B. CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol. 22:2002;554-559.
102. Simon D.I., Dhen Z., Seifert P., Edelman E.R., Ballantyne C.M., Rogers C. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest. 105:2000;293-300.
103. Ylitalo R. Bisphosphonates and atherosclerosis. Gen Pharmacol. 35:2002;287-296.
104. van Rooijen N., Sanders A. Elimination, blocking, and activation of macrophages: three of a kind? J Leukoc Biol. 62:1997;702-709.
105. Taylor A.J., Bobik A., Berndt M.C., Ramsay D., Jennings G. Experimental rupture of atherosclerotic lesions increases distal vascular resistance: a limiting factor to the success of infarct angioplasty. Arterioscler Thromb Vasc Biol. 22:2002;153-160.
106. Rekhter M.D., Hicks G.W., Brammer D.W., Hallak H., Kindt E., Chen J., Rosebury W.S., Anderson M.K., Kuipers P.J., Ryan M.J. Hypercholesterolemia causes mechanical weakening of rabbit atheroma: local collagen loss as a prerequisite of plaque rupture. Circ Res. 86:2000;101-108.
107. Rekhter M.D., Hicks G.W., Brammer D.W., Work C.W., Kim J.S., Gordon D., Keiser J.A., Ryan M.J. Animal model that mimics atherosclerotic plaque rupture. Circ Res. 83:1998;705-713.
108. Faber B.C., Cleutjens K.B., Niessen R.L., Aarts P.L., Boon W., Greenberg A.S., Kitslaar P.J., Tordoir J.H., Daemen M.J. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res. 89:2001;547-554.
109. Hiltunen M.O., Niemi M., Yla-Herttuala S. Functional genomics and DNA array techniques in atherosclerosis research. Curr Opin Lipidol. 10:1999;515-519.
110. McCaffrey T.A., Fu C., Du B., Eksinar S., Kent K.C., Bush H., Kreiger K., Rosengart T., Cybulsky M.I., Silverman E.S., Collins T. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest. 105:2000;653-662.
111. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
112. Lindmark E., Diderholm E., Wallentin L., Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA. 286:2001;2107-2113.
113. Blankenberg S., Tiret L., Bickel C., Peetz D., Cambien F., Meyer J., Rupprecht H.J. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 106:2002;24-30.
114. Johnstone M.T., Botnar R.M., Perez A.S., Stewart R., Quist W.C., Hamilton J.A., Manning W.J. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol. 21:2001;1556-1560.
115. Fayad Z.A., Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 89:2001;305-316.
116. El-Shafei A., Kern M.J. New techniques for the evaluation of the vulnerable plaque. J Invasive Cardiol. 14:2002;129-137.
117. Thieme T., Wernecke K.D., Meyer R., Brandenstein E., Habedank D., Hinz A., Felix S.B., Baumann G., Kleber F.X. Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol. 28:1996;1-6.
118. Uchida Y., Nakamura F., Tomaru T., Morita T., Oshima T., Sasaki T., Morizuki S., Hirose J. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J. 130:1995;195-203.
119. de Feyter P.J., Ozaki Y., Baptista J., Escaned J., Di Mario C., de Jaegere P.P., Serruys P.W., Roelandt J.R. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation. 92:1995;1408-1413.
120. Fayad Z.A., Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci. 902:2000;173-186.
121. Fischer A., Gutstein D.E., Fayad Z.A., Fuster V. Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease. Vasc Med. 5:2000;163-172.
122. Toussaint J.F., LaMuraglia G.M., Southern J.F., Fuster V., Kantor H.L. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 94:1996;932-938.
123. Frank H. Characterization of atherosclerotic plaque by magnetic resonance imaging. Am Heart J. 141:2001;S45-S48.
124. Fayad Z.A., Nahar T., Fallon J.T., Goldman M., Aguinaldo J.G., Badimon J.J., Shinnar M., Chesebro J.H., Fuster V. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation. 101:2000;2503-2509.
125. Stefanadis C., Diamantopoulos L., Vlachopoulos C., Tsiamis E., Dernellis J., Toutouzas K., Stefanadi E., Toutouzas P. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation. 99:1999;1965-1971.
126. Casscells W., Hathorn B., David M., Krabach T., Vaughn W.K., McAllister H.A., Bearman G., Willerson J.T. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 347:1996;1447-1451.
127. Rudd J.H., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., Johnstrom P., Davenport A.P., Kirkpatrick P.J., Arch B.N., Pickard J.D., Weissberg P.L. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 105:2002;2708-2711.
128. Chen J., Tung C.H., Mahmood U., Ntziachristos V., Gyurko R., Fishman M.C., Huang P.L., Weissleder R. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 105:2002;2766-2771.
129. Knight L.C. Radiolabeled peptide ligands for imaging thrombi and emboli. Nucl Med Biol. 28:2001;515-526.
130. Moreno P.R., Lodder R.A., Purushothaman K.R., Charash W.E., O'Connor W.N., Muller J.E. Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation. 105:2002;923-927.
131. Buschman H.P., Deinum G., Motz J.T., Fitzmaurice M., Kramer J.R., van der Laarse A., Bruschke A.V., Feld M.S. Raman microspectroscopy of human coronary atherosclerosis: biochemical assessment of cellular and extracellular morphologic structures in situ. Cardiovasc Pathol. 10:2001;69-82.
132. Peters R.J., Kok W.E., Havenith M.G., Rijsterborgh H., van der Wal A.C., Visser C.A. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiogr. 7:1994;230-241.
133. Hiro T., Fujii T., Yasumoto K., Murata T., Murashige A., Matsuzaki M. Detection of fibrous cap in atherosclerotic plaque by intravascular ultrasound by use of color mapping of angle-dependent echo intensity variation. Circulation. 103:2001;1206-1211.
134. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med. 347:2002;5-12.
135. Ikeda U., Matsui K., Murakami Y., Shimada K. Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol. 2002;143-147.